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Executive Summary 
 
 The collection of data on the Portable Document (PD) S2 which certifies the 
entitlement to scheduled treatment abroad under Regulations (EC) Nos 883/04 and 
987/09 was for the second time provided by Member States on a voluntary basis. It 
now covers the year 2013, and information was provided by 20 Member States. Data 
from a considerable number of issuing and receiving Member States are missing.  
 
 Some 30,541 PDs S2 were issued in 20 reporting countries, of which Luxembourg 
alone issued 17,539 PDs S2. Some 7,265 PDs S2 were received in 13 Member States 
reporting figures. However, the issuing and receiving flows are difficult to compare 
since they refer to different periods of time.  
 
 The number of PDs S2 issued by Member States for planned cross-border healthcare 
seems to be rather limited observing that only for about 15 out of 100,000 insured 
persons was a PD S2 issued in 2013.  
 
 Some 1,400 requests for a PD S2 were refused by 17 reporting Member States, 
representing 4.7% of the total number of requested PDs S2. The fact that care may 
be delivered within a medically acceptable period in the competent Member State is 
on average the most frequent reason to refuse a request (51.5% of refusals). 
Another 6.3% of refusals was related to the fact that the required care was not 
included in the services provided for by the legislation of the issuing Member State.  
 
 Despite the fact that the obligation for issuing the prior authorisation set out in 
Article 20 of Regulation (EC) No 883/2004 refers to treatments that are among the 
benefits provided by the Member States providing the authorisation, a number of 
Member States will issue a PD S2 also for care that is not included in the services 
provided for by their legislation. 
 
 Planned cross-border healthcare is significantly broader than only the PD S2 scheme. 
Several Member States report the existence of parallel procedures.  
 
 There is no clear view on the main grounds to receive planned cross-border 
healthcare. Push and pull factors may have an impact. Geographical proximity is 
only one possible reason, and only applicable to a number of Member States.    
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1. Introduction 
The Portable Document S2 (PD S2) ‘Entitlement to scheduled treatment’ (old E112 
form) certifies the entitlement to planned health treatment in a Member State (MS) 
other than the competent MS of the insured person.1 A questionnaire on the ‘old’ E112 
form was introduced between 2006 and 2008. The questionnaire was re-launched in 
2013 for the collection of data on PD S2 of reference year 2012. This report on the 
collection of data on PD S2 applies to reference year 2013 and was provided by the 
MSs on a voluntary basis. 
The scope of the present questionnaire was agreed in general terms with the 
delegations at the meeting of the Working Party of the Administrative Commission 
(AC) on cross-border healthcare on 17 April 2013. The finalised version of the 
questionnaire included in note AC 217/13 was approved by the majority of the MSs at 
the 335th meeting of the AC.  
The data collection should provide important information on the application of 
Regulation (EC) No 883/20042 but also on the future impact of Directive 2011/24/EU.3 
Differences in material scope4 and procedures with regard to prior authorisation5 and 
the reimbursement of costs6 between both may have an impact on the future 
evolution of the number of PDs S2 used.7  
                                          
1 Relevant for the EU/EEA countries and Switzerland. 
2 Regulation (EC) No 883/2004 of the European Parliament and of the Council of 29 April 2004 on the 
coordination of social security systems. See also Regulation (EC) No 987/2009 of the European Parliament 
and of the Council of 16 September 2009 laying down the procedure for implementing Regulation (EC) No 
883/2004 on the coordination of social security systems. 
3 Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of 
patients’ rights in cross-border healthcare. 
4 “… The Directive covers all providers, including non-contracted or private providers, while Regulation (EC) 
No 883/2004 does not impose any obligation on the MSs with regards to treatment given by providers who 
are not subject to the national legislation of the MS of treatment, such as certain non-contracted or private 
providers” (EC, 2012, ‘Guidance note of the Commission services on the relationship between Regulations 
(EC) Nos 883/2004 and 987/2009 on the coordination of social security systems and Directive 2011/24/EU 
on the application of patients’ rights in cross border healthcare’, AC 246/12, p. 4).  
5 The scope of Article 20 of Regulation (EC) No 883/2004 and Article 26(A) of Regulation (EC) No 987/2009 
should be compared with the scope of Article 8 of Directive 2011/24/EU. “As a rule, under the Regulations 
prior authorisation is a necessary requirement for receiving planned treatment in another MS. Under the 
Directive, a requirement of prior authorisation is not the rule. The MS of affiliation may provide for a system 
of prior authorisation only for certain kinds of cross-borders healthcare and only in so far as it is necessary 
and proportionate to the objective to be achieved, and not constitute a means of discrimination or an 
obstacle to the free movement of patients” (Ibid., p. 7). There is also a difference in procedure when 
residence is outside the competent MS. “When an insured person resides outside the MS of affiliation, the 
Directive can be used to request prior authorisation, if applicable, … directly from the MS of affiliation, 
subject to the specific conditions of the Directive. The procedure set out in Article 26 of Regulation (EC) No 
987/2009 determines that the insured person and members of the family submit in the MS of residence a 
request for prior authorisation in order to receive planned treatment in another MS. The prior authorisation 
is issued by the competent MS on the basis of an assessment made by the MS of residence” (EC, 2012, 
‘Guidance note of the Commission services on the relationship between Regulations (EC) Nos 883/2004 and 
987/2009 on the coordination of social security systems and Directive 2011/24/EU on the application of 
patients’ rights in cross border healthcare’, AC 246/12, p. 19 and p. 21). See also Hennion, S. & Kaufmann, 
O. (2014), Unionsbürgerschaft and Patientenfreizügigkeit – EU Citizenship and Free Movement of Patients – 
Citoyenneté Européenne et Libre Circulation des Patients, Springer, 437 p. 
6 The scope of Article 20(2) of Regulation (EC) No 883/2004 and Article 26(B)(C)(D) of Regulation (EC) No 
987/2009 should be compared with the scope of Article 7(4) of Directive 2011/24/EU. E.g. “The procedures 
and level of reimbursement of planned treatment under the Regulations and the Directive are different. 
Under the Regulations, reimbursement of healthcare received in the MS of treatment takes place in 
accordance with the legislation and tariffs of this MS. Under the Directive reimbursement takes place in 
accordance with the legislation and tariffs of the MS of affiliation” (EC, 2012, ‘Guidance note of the 
Commission services on the relationship between Regulation (EC) Nos 883/2004 and 987/2009 on the 
coordination of social security systems and Directive 2011/24/EU on the application of patients’ rights in 
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To facilitate the understanding of the frequently used terms, Figure 1 provides an 
overview of the potential exchange of documents between the involved MSs and the 
citizen. It enables us also to identify some of these exchanges. 
The insured person has to apply for a prior authorisation to receive a planned 
treatment outside the MS of residence / competent MS. Whether (or not) the insured 
person resides in the competent MS will influence the administrative procedure.8 If the 
insured person resides in the competent MS, (s)he must request a prior authorisation 
directly from the institution of the competent MS. In the event of a positive conclusion 
by the competent MS, a PD S2 will be granted to the insured person. If the insured 
person resides outside the competent MS, (s)he must request a prior authorisation 
from the institution of the MS of residence. The MS of residence will forward this 
request to the competent MS (using SED S009 ‘Request for entitlement document – 
scheduled treatment outside Member State of residence’). However, the MS of 
residence will examine whether the conditions to issue a PD S2 are met and will 
inform the competent MS of its conclusion using SED S009. Nevertheless, the 
competent MS still has the possibility to ask for additional information (e.g. request for 
a medical examination9) using SED S075 ‘Request additional info – scheduled 
treatment outside Member State of residence’ (reply using SED S076 ‘Reply to 
Request additional info – scheduled treatment outside MS of residence’). Finally, the 
competent MS informs the MS of residence whether the authorisation has been 
granted or not (using SED S010 ‘Reply to request for Entitlement Document – 
scheduled treatment outside MS of residence’). If the conclusion is positive, a PD S2 
will be granted to the insured person. Also the entitlement period (start and end date) 
will be indicated on SED S010 and PD S2.  
The competent MS, prior to issuing a PD S2, needs to know if the particular treatment 
is provided by the MS of stay and this within a time limit which is medically justifiable 
(request using SED S014 ‘Request for information as if treatment is provided for by 
Member State of Stay – Scheduled Treatment’ and reply using SED S015 ‘Information 
if treatment is provided for by Member State of stay – scheduled treatment’). Also the 
estimated cost of the treatment could be asked by the competent MS using SED S014 
(which will be answered using SED S015). 
Finally, the MS of stay could ask for an extension of the entitlement period using 
SED S035 ‘Request for extension of entitlement document – scheduled treatment’. 
The competent MS has to acknowledge the receipt of the request using SED S036 
‘Acknowledgement of request for extension of entitlement document – scheduled 
treatment’. The competent MS then informs the MS of stay about whether the 
extension of the entitlement document has been granted or not (using SED S037 
‘Reply to request for extension of entitlement document – scheduled treatment’). If 
the entitlement is extended, no new PD S2 will be granted to the insured person. 
                                                                                                                             
cross border healthcare’, AC 246/12, p. 14). See also Hennion, S. & Kaufmann, O. (2014), 
Unionsbürgerschaft and Patientenfreizügigkeit – EU Citizenship and Free Movement of Patients – 
Citoyenneté Européenne et Libre Circulation des Patients, Springer, 437 p. 
7 As the Directive was transposed only at the end of last year, we can consider the data collection for 2013 
as a baseline measurement. 
8 If the insured person does not reside in the competent MS: see Article 26(2) of Regulation (EC) No 
987/2009. 
9 See Article 26(2) of Regulation (EC) No 987/2009.  
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Figure 1 The current and future flow of documents applicable to planned healthcare 
treatment in another MS 
 
Source Own figure based on SEDs 
2. The number of PDs S2 issued and received 
2.1. The current flow of PDs S2 between MSs 
Table 1 gives a detailed overview of the PDs S2 issued by 20 reporting MSs.10 In 2013, 
these reporting MSs issued a total number of 30,541 PDs S2. Patient mobility, in this 
report limited to planned cross-border healthcare related to a PD S2, seems to be 
rather low observing this total figure.11 57% of the reported PDs S2 were issued by LU 
(17,539 PD S2 issued).12 This MS mainly granted PDs S2 to receive scheduled 
                                          
10 Reporting MSs: BE, BG, CZ, EE, IE, EL, IT, LV, LT, LU, HU, MT, NL, PL, PT, RO, SK, FI, UK and LI. 
11 However, limited to the application of Regulation (EC) No 883/2004. Also Directive 2011/24/EU or other 
parallel procedures defined by MSs will influence planned cross-border healthcare.  
12 Below, possible reasons for planned cross-border mobility from / to a MS are discussed. A possible reason 
for the high number of PDs S2 issued by LU could be the fact that “In some MSs, especially in the smaller 
ones, it may not convenient to provide some medical treatments in their territories. Thus, patients from 
smaller MSs are more likely to travel to another MS to receive a particular care that is not provided in their 
MSs of affiliation” (Forchielli, F., Fusco, M., Pessina, E., Domeniconi, W., Ricciardi, W. (2008), Patient 
mobility in the European Union. Study on Legislative Proposals on Patients’ Rights in Cross-Border Health 
Care, European Parliament, p. 14. Jorens, Y. (2007, Cross-border health care: E112, trESS, p.12) reports 
that “in some countries, treatments for some diseases might not be available for lack of sufficient cases 
(due to the small population) or because treatment facilities have not been developed due to the very 
specialised character of the treatment. … This is the case in, inter alia,  … Luxembourg”. When certain 
treatments are not provided by a national healthcare system, the reason behind this can be purely economic 
if financing the treatment or setting up the necessary infrastructure were too expensive and uneconomic. 
This is the case for highly specialised treatments, which would result in unprofitable investments if the 
population of the MS is rather small. See among others Glinos, I. & Baeten, R. (2006), A literature Review 
of Cross-Border Patient Mobility in the European Union, Brussels, European Observatory on Health Systems 
and Policies, p. 6.  
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treatment in a neighbouring MS (DE, BE and FR). Also BE13, IT, NL, UK and PL issued 
more than one thousand prior authorisations in 2013 while PL, FI, PT, LT and MT 
issued less than one hundred PDs S2. No total figure on the number of PDs S2 issued 
by the EU/EEA countries and Switzerland is yet available. However, we estimate that 
in total more than 50,000 PDs S2 were issued. This estimate is based on the average 
percentage of insured persons who received a PD S2 from a reporting MS (15 out of 
100,000 insured persons – see below). 
These absolute figures could be confronted with the total number of insured persons 
(Table A2.1 – Annex 2). For about 15 out of 100,000 insured persons a PD S2 was 
issued in 2013.14 We observe a rather high patient mobility for persons insured in LU 
(2 out of 100 insured persons) and LI (7 out of 1,000 insured persons). 
A breakdown by receiving MS makes it possible to determine the highest bilateral 
flows. Table A2.2 (Annex 2) provides the share of the receiving MS of the total 
number of PDs S2 issued by the competent MS (as a percentage of the total number 
of PDs S2 issued by the competent MS). This Table also visualises the three MSs for 
which the highest number of PDs S2 were issued by each of the competent MSs 
separately. The main receiving MSs for the reporting competent MSs (in terms of PDs 
S2 received as well as in terms of the number of times in the top 3 as receiving MS) 
are DE, FR and BE. 
No distinction could be made in the number of PDs S2 issued between insured persons 
residing in or outside the competent MS. As described above, the administrative 
procedure will be different for both cases. 
Only 13 MSs15 provided figures on the number of PDs S2 received (Table 2). BE 
received 3,318 PDs S2 during the first semester of 2013 mainly issued by 
neighbouring MSs (NL, LU, FR and DE).16 Based on Tables 1 and 3 also DE and FR 
should receive a high number of PDs S2. However, these MSs did not provide any data 
on the number of PDs S2 received in 2013. LU and UK also received more than one 
thousand PDs S2 in 2013. This is in contrast to BG, IE, LV and RO, which received less 
than 10 PDs S2. 
Table A2.3 (Annex 2) provides the share of the issuing MS of the total number of PDs 
S2 received by the receiving MS (as a percentage of the total number of PDs S2 
received by the receiving MS). This Table also visualises the three MSs with the 
highest number of PDs S2 issued for each of the receiving MSs separately. The main 
issuing MS for the reporting receiving MSs (only in terms of the number of times in the 
top 3 as issuing MS) are DE and UK. 
It would be interesting to determine the main reasons for asking/receiving planned 
cross-border healthcare (from/to a MS). Different push and pull factors may have an 
impact on this decision.17 The treatment should in any case, within the PD S2 scheme, 
                                          
13 BE is also involved in a large number of cooperation agreements in border areas (i.e. IZOM, ZOAST …) 
where, depending on the cooperation agreement, prior authorisation (using PD S2) often becomes a simple 
administrative authorisation that is granted automatically. The number of prior authorisations for this type 
of planned cross-border care is reported separately. 
14 Average of the reporting MSs. 
15 Reporting MSs: BE, BG, CZ, IE, LV, LT, LU, HU, PL, RO, SK, FI and UK. 
16 During the first semester of 2013 BE also received 7,818 authorisations within the ZOAST agreement 
(issued by FR and LU). 
17 See also European Commission (2007), Flash Eurobarometer 210 – Cross-border health services in the EU 
– Analytical Report, 42 p; Glinos, A. & Baeten, R. (2006), A Literature Review of Cross-border Patient 
Mobility in the European Union, OSE, 114 p.; Wismar, M., Palm, W., Figueras, J., Ernst, K. & van Ginneken, 
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be provided for by the legislation of the competent MS and the MS of treatment.18 The 
fact that the treatment could not be delivered within a medically acceptable period in 
the competent MS will play an important role.19 Also other push factors, among others 
the lack of treatment facilities or expertise in the competent MS may influence the 
decision to grant a PD S2. Multiple pull factors are thinkable to receive a scheduled 
treatment in one particular MS (e.g. proximity, language, medical expertise/quality, 
financial reasons (e.g. reimbursement rates, out-of-pocket expenses …)).  
The extent of the importance of all these push and pull factors should be verified. 
However, the current PD S2 Questionnaire did not ask MSs to provide qualitative input 
on this issue. Based on the current quantitative input some first analyses could be 
made. We have verified the importance of proximity to receive/issue a PD S2. Tables 
A2.2 and A2.3 (Annex 2) visualise the percentage of PDs S2 issued by / received from 
a neighbouring MS. About 80% of the reported PDs S2 are issued by a neighbouring 
MS. Most of the PDs S2 issued by BE, CZ, IE, IT, LV, LU, NL, MT, PL, SK and LI are 
applicable to a neighbouring MS (Table A2.2). BG, EE, EL, LT, HU, PT, RO, FI and UK 
issued less than 50% of the PDs S2 for a neighbouring MS. BE, CZ, IE, LT, LU, SK, FI 
and UK received most of the PDs S2 from neighbouring MSs (Table A2.3). This is not 
the case for BG, HU, PL and RO.  
 
   
                                                                                                                             
E. (2011), Cross-border Health Care in the European Union. Mapping and analyzing practices and policies, 
European Observatory on Health Systems and Policies, 376 p; Jorens. Y (2007), Cross-border health care: 
E-112, trESS, UGent, 18 p. 
18 Article 20(2) of Regulation (EC) No 883/2004. In practice this will not always be the case (see below). 
19 So the existence of waiting lists, which may result in longer waiting times, could influence to a high extent 
the granting of a prior authorisation. See also Hennion, S. & Kaufmann, O. (2014), Unionsbürgerschaft and 
Patientenfreizügigkeit – EU Citizenship and Free Movement of Patients – Citoyenneté Européenne et Libre 
Circulation des Patients, Springer, 437 p. 
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Table 1 The number of PDs S2 issued, breakdown by receiving MS, 2013* 
Receiving  
 MS   
BE 
*** 
BG CZ DK DE EE IE EL ES FR HR IT CY LV LT LU HU MT 
*****
 
NL AT PL PT RO SI SK FI 
******
 
SE UK EU 
28 
IS LI NO CH Tot 
******* 
BE  61 2   0 14 24    257  1 3 4300 1 0 1014  13 1 23  1 0  45 5760  0   5760 
BG 2 0 0   0 0 0    0  0 0 0 0 0 0  0 0 1  0 0  10 13  0   13 
CZ 2 0 0   0 0 0    7  0 0 5 0 0 2  0 0 1  587 0  44 648  0   648 
DK 1 0 0   0 0 0    0  4 2 1 0 0 0  0 0 0  0 0  3 11  0   11 
DE 530 119 30   20 6 112    839  58 28 10156 95 0 203  44 3 457  52 13  82 12847  1   12848 
EE 1 0 0   0 0 0    0  24 10 0 0 0 0  0 0 0  0 11  1 47  0   47 
IE  0 0   0 0 0    0  0 0 1 0 0 0  0 0 0  0 0  13 14  0   14 
EL 1 1 0   0 0 0    0  0 0 2 0 0 0  0 0 0  0 0  7 11  0   11 
ES 11 1 0   1 0 0    40  0 0 14 0 0 0  0 4 4  0 1  200 276  0   276 
FR 311 19 0   0 0 79    1295  1 1 2483 6 0 10  2 16 121  5 2  134 4485  0   4485 
HR  0 6   0 0 0    0  0 0 0 0 0 0  0 0 0  0 0  1 7  0   7 
IT 6 6 0   0 1 82    304****  0 0 52 0 14 0  4 2 127  1 1  31 631  0   631 
CY 1 0 0   0 0 0    0  0 0 0 0 0 0  0 0 0  0 0  2 3  0   3 
LV  0 0   0 0 0    0  0 0 0 0 0 0  0 0 0  0 0  1 1  0   1 
LT  0 0   0 0 0    0  66 0 0 0 0 0  0 0 0  0 0  14 80  0   80 
LU 52 0 0   0 0 0    2  0 0 0 0 0 0  0 0 0  0 0  3 57  0   57 
HU  0 1   0 0 0    1  0 0 4 0 0 0  0 1 59  0 0  28 94  0   94 
MT  0 0   0 0 0    0  0 0 0 0 0 0  0 0 0  1 0   1  0   1 
NL 226 1 5   1 6 1    24  6 15 47 0 0 0  3 0 5  4 0  19 363  0   363 
AT 2 17 1   0 1 92    179  0 0 24 96 0 0  2 0 236  102 0  12 764  5   769 
PL 1 2 1   0 8 0    18  1 6 3 0 0 0  0 0 1  3 0  423 467  0   467 
PT 1 0 0   0 0 0    0  0 0 37 0 0 0  0 0 0  0 0  3 41  0   41 
RO  0 0   0 0 0    0  0 0 0 0 0 0  0 0 0  0 1  2 3  0   3 
SI  0 0   0 0 0    1  0 0 1 0 0 0  0 0 0  0 0  0 2  0   2 
SK  0 8   0 0 0    3  1 0 0 1 0 0  0 0 1  0 0  96 110  0   110 
FI 1 0 3   16 0 0    2  4 0 3 0 0 1  0 0 0  0 0  5 35  0   35 
SE  6 1   3 28 7    22  2 0 9 1 0 0  2 0 0  1 2  12 96  0   96 
UK 24 1 2   11 617 66    128  4 3 22 5 0 2  13 1 5  4 1  10 919  0   919 
EU28 1173 234 60   52 681 463    3122  172 68 17164 205 14 1232  83 28 1041  761 32  1201 27786  6   27792 
IS  0 0   0 0 0    0  0 0 0 0 0 0  0 0 0  0 0  0 0  0   0 
LI  0 0   0 0 0    0  0 0 0 0 0 0  0 0 0  0 0  0 0  0   0 
NO  0 0   0 0 0    0  0 0 0 0 0 0  0 0 0  0 0  1 1  0   1 
CH 17 1 4   0 2 23    1811  2 6 374 129 19 32  5 0 0  8 0  14 2447  255   2702 
N.s.**  0 36   0 0 0    0  0 0 1 0 0 0  0 0 8  0 2  0 46  0   46 
Tot. 1190 235 100   52 683 486    4933  174 74 17539 334 33 1264  88 28 1049  769 34  1216 30280  261   30541 
* blank: non-response. 
** N.s.: not specified. 
*** BE: + 5,430 authorisations in 2013 of which IZOM agreement: 4,036; ZOAST agreement: 102; main residence in a border region: 748; functional 
rehabilitation in DE for insured persons living in the German-speaking community and maternity (Decision at the 254th meeting of the AC): 148.  
**** IT: search for bone marrow donor within the EU/EEA area. 
*** ** MT: total reported in PD S2 Questionnaire of MT: 23. 
****** FI: only for the second semester of 2013. Total 2013= 59 PDs S2 issued. 
*** **** EU28 = 30,305 and total = 30,566 if ***** is taken into account. 
Source Administrative data PD S2 Questionnaire 2014 and 2013 
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Table 2 The number of PDs S2 received, breakdown by issuing MS, 2013* 
Issuing 
MS  
BE 
**(*) 
BG CZ 
**** 
DK DE EE IE EL ES FR HR IT CY LV LT LU HU MT NL AT PL PT RO SI SK FI 
***** 
SE UK EU 
28 
IS LI NO CH Tot 
****** 
BE   2 2    0       0 0 655 0    2  0  1 1  7 670     670 
BG 26 0  0    0       0 0 0 0    0  0  1 0  2 29     29 
CZ 1 0  0    0       0 0 0 0    1  0  182 0  0 184     184 
DK 3 0 0     0       0 0 0 0    0  0  1 0  12 16     16 
DE 43 1 38     0       0 0 101 32    113  1  21 0  5 355     355 
EE  0 0     0       0 0 0 1    0  0  0 16  5 22     22 
IE 3 0 0    0        0 0 0 0    8  0  0 0  868 879     879 
EL 21 0 0    0        0 0 0 0    0  0  0 0  60 81     81 
ES 7 0 8    0        0 0 5 0    3  0  1 9  7 40     40 
FR 269 0 8    0        0 0 316 1    4  0  1 0  5 604     604 
HR  0 0    0        0 0 0 0    0  0  0 0  0 0     0 
IT 150 0 10    0        0 0 2 1    8  0  2 0  54 227     227 
CY  0 0    0        0 0 0 0    0  0  0 0  12 12     12 
LV 2 0 0    0        0 49 0 0    0  0  0 1  2 54     54 
LT  0 0    0       0  0 0 0    7  0  0 0  4 11     11 
LU 1113 0 0    0       0 0  0 2    0  0  0 0  8 1123     1123 
HU 2 0 0    0       0 0 0  0    0  0  1 0  1 4     4 
MT  0 0    0       0 0 0 0     0  0  0 0  0 0     0 
NL 1615 0 1    0       0 0 11 0     5  0  0 0  5 1637     1637 
AT 2 0 6    0       0 0 0 1     1  0  13 0  3 26     26 
PL 12 0 2    0       0 0 0 3     0  0  1 0  5 23     23 
PT 2 0 0    0       0 0 0 0    0   0  0 0  0 2     2 
RO 15 0 2    0       0 0 0 5    0   0  1 0  4 27     27 
SI 2 0 2    0       0 0 0 0    0  0   0 0  4 8     8 
SK 5 0 754    0       0 0 0 0    0  0   0 0  1 760     760 
FI 2 0 0    0       0 0 1 0    0  0  0  0  0 3     3 
SE 4 0 0    0       0 0 0 0    0  0  0 2   3 9     9 
UK 19 2 99    4       0 1 4 2    253  1  64 0  0  449     449 
EU28 3318 5 932   n.a. 4 n.a.    n.a.  0 50 1095 48 n.a. n.a.  405 n.a. 2  290 29  1077 7255  n.a.   7255 
IS  0 0    0       0 0 0 0    0  0  0 0  0 0      0 
LI  0 0    0       0 0 0 0    0  0  0 0  0 0      0 
NO  0 2    0       0 0 0 0    3  0  0 0  0 5      5 
CH  0 0    0       0 0 0 0    0  0  2 0  3 5      5 
Tot. 3318 5 934   n.a. 4 n.a.    n.a.  0 50 1095 48 n.a. n.a.  408 n.a. 2  292 29  1080 7265  n.a.   7265 
* n.a.: no data available; blank: non-response. 
** BE: only for the first semester of 2013. Figures were obtained from Belgian claims relating to healthcare benefits for which the competent 
institution granted prior authorisation and which were covered by Belgian institutions during the first semester of 2013. 
*** BE: + 7,852 authorisations within ZOAST (border regions), 7,818 of which issued by FR and 34 issued by LU. 
**** CZ: total reported in PD S2 Questionnaire of CZ: 913. 
***** FI: only for the second semester of 2013. No total for 2013 reported. 
****** Including figures for FI (only for the second semester of 2013) and BE (only for the first semester of 2013). 
Source Administrative data PD S2 Questionnaire 2014 and 2013 
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Figure 2 gives an overview of the net balance of PDs S2 (the number of PDs S2 issued 
minus the number of PDs S2 received) per MS. Most of the reporting MSs are ‘net 
senders’ (LU, RO, IE, SK, HU, BG, UK, LV and LT). Only PL and CZ are ‘net recipients’. 
The net balance will be the result of an interchange of push and pull factors described 
above.   
Figure 2 The net balance between PDs S2 issued and received, 2013* 
 
* n.a.: BE, EE, GR, IT, MT, NL, PT, FI, LI; blank: DK, DE, ES, FR, HR, CY, SI, SE, IS, NO, CH.
 Source Administrative data PD S2 Questionnaire 2014 
2.2. 2013 vs 2012: a comparison 
The current data collection (reference year: 2013) could be compared to the previous 
one (reference year: 2012). The number of PDs S2 issued (-2.3%) and received        
(-12.6%) decreased in 2013 compared to 2012.20  
Compared to 2012 BG (+82%), EL (+53%), FI (+31), LV (+12%), UK (+8%), IT 
(+6%) and SK (+5%) issued more PDs S2 in 2013, while CZ (-64%), NL (-34%), CZ 
(-25%), IE (-19%), BE (-7%), RO (-7%), PT (-3%) and LU (-1%) issued less forms. 
HU (+200%), BG (+150%) and PL (+69%) received more forms compared to 2012. 
RO received the same number of forms and LV (-100%), UK (-28%), BE (-17%), SK 
(-17%), CZ (-4%) and LU (-2%) received less PDs S2 compared to 2012.  
The evolution of the number of PDs S2 issued/received over the past years could be 
influenced by legislative changes. We might expect a change here in the number of 
PDs S2 issued in connection with the provisions of Directive 2011/24/EU.21 
 
                                          
20 Total weighted average of the MSs which reported figures for both years. 
21 However, it is very uncertain how the Directive might affect the number of PDs S2 issued. 
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 Table 3 The number of PDs S2 issued and received, 2012-2013* 
MS Issued 
2013 
Issued 
2012 
% change Received 
2013 
Received 
2012 
% change 
BE 1,190 1,280 -7.0% 3,318** 4,019*** -17.4% 
BG 235 129 82.2% 5 2 150.0% 
CZ 100 281 -64.4% 934 973 -4.0% 
DK       
DE       
EE 52   n.a.   
IE 683 847 -19.4% 4 8 -50.0% 
EL 486 318 52.8% n.a. n.a.  
ES       
FR       
HR       
IT 4,933 4,661 5.8% n.a. n.a.  
CY       
LV 174 156 11.5% 0 1 -100.0% 
LT 74   50   
LU 17,539 17,765 -1.3% 1,095 1,120 -2.2% 
HU 334 300 11.3% 48 16 200.0% 
MT 33   n.a.   
NL 1,264 1,940 -34.8% n.a. 4,782  
AT       
PL 88 118 -25.4% 408 241 69.3% 
PT 28 29 -3.4% n.a. n.a.  
RO 1,049 1,131 -7.3% 2 2 0.0% 
SI       
SK 769 730 5.3% 292 353 -17.3% 
FI 59 45 31.1% n.a.**** n.a.  
SE  81   216  
UK 1,216 1,126 8.0% 1,080 1,491 -27.6% 
Selection 
******* 
30,146 30,856 -2.3% 7,186***** 8,226****** -12.6% 
IS       
LI 261   n.a.   
NO       
CH       
Total    ***   
* n.a.: no data available; blank: non-response. 
** BE: only for the first semester of 2013. 
*** BE.: only for the second semester of 2012. 
**** FI: only for the second semester of 2013: 29 PDs S2 received. 
***** Including figures for FI (only for the second semester of 2013) and BE (only for the 
first semester of 2013). 
****** Including figures for BE (only for the second semester of 2012) 
******* Selection: we have only selected those MSs which reported figures for both years. 
16 MSs (BE, BG, CZ, IE, EL, IT, LV, LU, HU, NL, PL, PT, RO, SK, FI and UK) reported the 
number of PDs S2 issued for 2012 and 2013. 11 MSs (BE, BG, CZ, IE, LV, LU, HU, PL, RO, 
SK and UK) reported the number of PDs S2 received for 2012 and 2013. 
Source Administrative data PD S2 Questionnaire 2014 and 2013 
2.3. Differences between issuing and receiving flows of PDs S2 
Different reasons may explain the discrepancy between the reported bilateral flows of 
issuing and receiving PDs S2 (see Tables 1 and 2). Firstly, the period of time between 
the date of the decision to issue a PD S2 and the date the PD S2 was received by the 
appropriate healthcare institution will have an important impact on the discrepancy 
between the number of PDs S2 issued and received.22 Secondly, not every insured 
                                          
22 The questionnaire requested the number of issued PDs S2 determined by the dates of the decisions to 
issue an authorisation for issuing a PD S2, even if the request for authorisation was received in year-1 and 
the number of received PDs S2 determined by the dates the PD S2 was received by the appropriate 
healthcare institution in the reporting country.  
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person who received a prior authorisation will eventually use this. For these reasons 
the evolution of the number of PDs S2 received and issued should be observed 
separately.  
3. Treatment of the request and reasons for refusal 
About 1,400 requests for a PD S2 were refused by the 17 reporting MSs23 in 2013 
(Table 4). LU (613) and BE (366) refused the highest number of requests (in absolute 
values). This is in contrast to LT and LI, which refused none of the requests.  
However, in order to obtain the authorisation/refusal rate these absolute values should 
be confronted with the number of PDs S2 issued (Table 5 and Table A2.4 – Annex 2). 
In 2013, only 4.7% of the requests for a PD S2 were refused, which implies a very 
high authorisation rate of 95.3%. FI refused almost 58% of the requests (Table 5). 
BE, CZ, PL and PT also show a rather high refusal rate (higher than 20%). The other 
MSs refused less than 10% of the applications (BG, EE, GR, LV and SK); IE, IT, LU, RO 
and UK even less than 5% of the applications; LT and LI even accepted all requests.  
But, also bilateral differences between MSs will appear (Table A2.4 – Annex 2). Based 
on the data presented it was assessed whether some MSs of treatment show a higher 
refusal rate. It is in any case possible that the treatment could not be provided for by 
the legislation of the MS of treatment or could not be given in the MS of treatment 
within a time limit which is medically justifiable.24 All applications that indicated IE, 
HR, CY, MT and SI as the MS where the scheduled treatment will be provided were 
accepted. However, for these MSs only a low number of PDs S2 are issued by the 
competent MSs. There is no indication that the authorisation/refusal rate will be 
influenced by the proposed MS of treatment. 
                                          
23 Reporting MSs: BE, BG, CZ, EE, IE, EL, IT, LV, LT, LU, PL, PT, RO, SL, FI, UK and LI. 
24 Perhaps also the treatment cost (requested by SED S014 ‘Request for information as if treatment is 
provide for by Member State of Stay – Scheduled Treatment’ and replied by SED S015 ‘Information if 
treatment is provided for by Member State of stay – scheduled treatment’) is a reason to refuse the request 
by the competent MS or to issue a PD S2 for treatment in a MS with lower costs? 
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Table 4 The number of PDs S2 refused, breakdown by the proposed MS of treatment, 2013* 
Proposed  
MS of 
treatment 
BE BG CZ DK DE EE IE EL ES FR HR IT CY LV 
*** 
LT LU HU MT NL AT PL PT RO SI SK FI 
**** 
SE UK EU 
28 
IS LI NO CH Tot 
***** 
BE   5 2   0 1 0    4  1  102     1 0 1  1 1  0 119  0   119 
BG 1 0 0   0 0 0    0  0  0     0 0 0  1 2  0 3  0   4 
CZ 4 0  0   0 0 0    1  0  2     0 0 0  40 0  0 43  0   47 
DK  0 0    0 0 0    1  1  4     0 0 0  1 0  0 7  0   7 
DE 84 9 14    1 2 18    26  3  357     16 5 13  2 6  0 472  0   556 
EE  0 1    0 0 0    0  2  0     0 0 0  0 25  0 28  0   28 
IE  0 0   0  0 0    0  0  0     0 0 0  0 0  0 0  0   0 
EL 2 1 0   0 0  0    0  0  0     0 0 0  0 0  0 1  0   3 
ES 4 0 0   0 0 0     8  0  6     0 2 2  0 1  2 21  0   25 
FR 111 1 1   0 0 2     27  0  78     2 3 3  3 0  2 122  0   233 
HR  0 0   0 0 0     0  0  0     0 0 0  0 0  0 0  0   0 
IT 7 0 1   0 0 1    1
**  0  11     2 0 4  0 0  1 21  0   28 
CY  0 0   0 0 0    0   0  0     0 0 0  0 0  0 0  0   0 
LV  0 0   0 0 0    0   0  0     0 0 0  0 1  0 1  0   1 
LT  0 0   0 0 0    0  1   0     0 0 0  0 0  0 1  0   1 
LU 15 0 0   0 0 0    0  0   0     0 0 0  0 0  0 0  0   15 
HU 2 0 0   0 0 0    0  0  0      0 0 2  2 0  0 4  0   6 
MT  0 0   0 0 0    0  0  0      0 0 0  0 0  0 0  0   0 
NL 111 1 0   0 0 0    1  2  5      0 1 1  0 0  0 11  0   122 
AT 1 2 2   0 1 1    12  0  6      0 0 6  7 0  0 37  0   38 
PL 4 0 0   0 1 0    0  0  2      0 0 0  0 0  0 3  0   7 
PT 1 0 0   0 0 0    0  0  14     0  0 0  0 0  0 14  0   15 
RO  0 0   0 0 0    0  0  2     0 0  0  0 0  0 2  0   2 
SI  0 0   0 0 0    0  0  0     0 0 0   0 0  0 0  0   0 
SK  0 4   0 0 0    1  0  0     0 0 0   0 0  1 6  0   6 
FI 1 0 0   5 0 0    0  0  0     0 0 0  0  0  0 5  0   6 
SE  0 0   0 2 0    2  1  4     0 0 0  0 1   0 10  0   10 
UK 9 0 0   0 19 12    2  0  5     3 0 1  0 0   0 42  0   51 
EU28 357 19 25   6 26 34    86  11 0 598 n.a. n.a. n.a.  24 11 33  57 37  6 973  0   1330 
IS  0 0   0 0 0    0  0  0     0 0 0  0 0  0 0   0   0 
LI  0 0   0 0 0    0  0  0     0 0 0  0 0  0 0   0   0 
NO  0 0   0 0 0    0  0  0     0 0 0  0 0  0 0  0    0 
CH 9 0 0   0 0 0    21  0  15     0 0 1  1 1  0 39  0    48 
Tot. 366 19 25   6 26 34    107  11 0 613 n.a. n.a. n.a.  24 11 34  58 38  6 1012  0   1378 
* n.a.: no data available; blank: non-response. 
** IT: search for bone marrow donor within the EU/EEA area. 
*** LV: 2 forms not specified. Total 2013 = 13. 
**** FI: only for the second semester of 2013. Total 2013= 81 PD S2 refused. 
*** ** Total = 1,423 PDs S2 refused if *** and **** are taken into account. 
Source Administrative data PD S2 Questionnaire 2014 
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Table 5 The number of requests PDs S2 refused and accepted, 2013* 
Issuing
MS 
Number of PDs 
S2 issued (A) 
Number of PDs 
S2 refused (B) 
Total 
(= number of 
requests) (C) 
% accepted 
(A/C) 
% refused 
(B/C) 
BE 1190 366 1556 76.5% 23.5% 
BG 235 19 254 92.5% 7.5% 
CZ 100 25 125 80.0% 20.0% 
DK      
DE      
EE 52 6 58 89.7% 10.3% 
IE 683 26 709 96.3% 3.7% 
EL 486 34 520 93.5% 6.5% 
ES      
FR      
HR      
IT 4,933 107 5,040 97.9% 2.1% 
CY      
LV 174 13 187 93.0% 7.0% 
LT 74 0 74 100.0% 0.0% 
LU 17,538 613 18,151 96.6% 3.4% 
HU 334 n.a. n.a. n.a. n.a. 
MT 33 n.a. n.a. n.a. n.a. 
NL 1,264 n.a. n.a. n.a. n.a. 
AT      
PL 88 24 112 78.6% 21.4% 
PT 28 11 39 71.8% 28.2% 
RO 1,049 34 1,083 96.9% 3.1% 
SI      
SK 769 58 827 93.0% 7.0% 
FI 59 81 140 42.1% 57.9% 
SE      
UK 1,216 6 1,222 99.5% 0.5% 
EU28 29,115 1,057 30,172 95.3%** 4.7%** 
IS      
LI 261 0 261 100.0% 0.0% 
NO      
CH      
Total 29,376 1,057 30,433 95.3%** 4.7%** 
* n.a.: no data available; blank: non-response. 
** Weighted average EU28: MS is only taken into account when columns (A) and (B) are 
known. 
Source Administrative data PD S2 Questionnaire 2014 
The fact that care may be delivered within a medically acceptable period in the 
competent MS is on average the most frequent reason to refuse a request for a PD S2 
by the reporting competent MSs (52% of refusals) (Table 6). It was the main reason 
for BG, CZ, EE, IE, EL, IT, HU, PL, PT, SK and FI. On average 6% of the requests were 
refused by the reporting competent MSs because the care in question was not 
included in the services provided for by the legislation of the competent MS, however 
this was not the main reason to refuse requests for any reporting MS. Finally, for 42% 
of the refusals other circumstances were the main reason to refuse a request.25 BE, 
LV, LU, RO and UK indicated ‘other reasons’ to refuse most of the applications. 
 
                                          
25 Also reasons within the MSs of stay could have an impact on the refusal of an application (e.g. treatment 
is not provided for by the legislation of the MS of stay or not given within a time limit which is medically 
justifiable or has a (very) high expected cost …).  
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Table 6 Reasons for refusal to issue a PD S2, 2013 (as a % of the total of refused requests)* 
Issuing 
MS 
The care in question is not 
included in the services 
provided for by the 
legislation of your MS 
The care in question may be 
delivered within a medically 
acceptable period in the 
competent MS 
Other circumstances (e.g. 
incomplete file, non-
compliance with procedures, 
institution requesting a 
second opinion …) 
BE  3.0% 42.9% 54.1% 
BG 0.0% 100.0% 0.0% 
CZ 36.0% 44.0% 20.0% 
DK    
DE    
EE 0.0% 100.0% 0.0% 
IE 0.0% 69.2% 30.8% 
EL 12.5% 75.0% 12.5% 
ES    
FR    
HR    
IT 6.5% 81.3% 12.1% 
CY    
LV 38.5% 0.0% 61.5%** 
LT    
LU 4.4% 47.5% 48.1% 
HU 0.0% 100.0%*** 0.0%**** 
MT 0.0% 0.0% 0.0% 
NL n.a. n.a. n.a. 
AT    
PL 37.5% 62.5% 0.0% 
PT 9.1% 90.9% 0.0% 
RO 35.3% 5.9% 58.8% 
SI    
SK 1.7% 58.6% 39.7% 
FI 2.6% 94.7% 2.6% 
SE    
UK 0.0% 0.0% 100.0% 
EU28 6.3% 51.5% 42.2% 
IS    
LI 0.0% 0.0% 0.0% 
NO    
CH    
Total 6.3% 51.5% 42.2% 
* n.a.: no data available; blank: non-response. 
** LV: 3 due to the death of the patient; 4 incomplete files; 1 patient withdrew its application. 
*** HU: please note that these data involve all refusals of planned treatments abroad and not 
only refusals of requests for issuing PDs S2. 
**** Remark of HU: “Reasons mentioned in the field are administrative issues. They cannot 
be absolute reasons for refusal”. 
Source Administrative data PD S2 Questionnaire 2014 
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The 16 reporting MSs26 received 120 contested decisions to refuse authorisation to 
issue a PD S2. On average 13% of the decisions to refuse a request were contested 
(Table 7). This seems a rather high percentage. For example for 2007 “the percentage 
of refusal decisions which were contested remained very low (in the majority of cases, 
less than 1%)” (CA.SS.TM. 223/08). In HU 42% of the refused requests were 
contested.27 Also BG, CZ, EE, IE, GR, LV, SK and FI show a higher percentage of 
contested decisions compared to the total average of the reporting MSs. In PT, RO and 
UK none of the decisions to refuse a PD S2 were contested. 
Table 7 The percentage of contested decisions to refuse to issue a PD S2, 2013* 
MS Number of contested 
decisions  
(A) 
Number of refusals  
(B) 
% of contested decisions to 
refuse to issue a PD S2 
(A/B) 
BE n.a. 366 n.a. 
BG 3 19 15.8% 
CZ 6 25 24.0% 
DK    
DE    
EE 1 6 16.7% 
IE 4 26 15.4% 
EL 8 32 25.0% 
ES    
FR    
HR    
IT n.a. 107 n.a. 
CY    
LV 2 13 15.4% 
LT 0 0  
LU 56 613 9.1% 
HU** 22 52 42.3% 
MT 0 n.a.  
NL n.a. n.a. n.a. 
AT    
PL n.a. 24 n.a. 
PT 0 11 0.0% 
RO 0 34 0.0% 
SI    
SK 12 58 20.7% 
FI 6 38 15.8% 
SE    
UK 0 6 0.0% 
EU28*** 120 1,378 12.9% 
IS    
LI 0 0  
NO    
CH    
Total 120 1,378 12.9% 
* n.a.: no data available; blank: non-response. 
** HU: please note that these data are for contested decisions on refusing planned treatments 
abroad and not only for cases concerning PD S2. 
*** EU28 weighted average: MS is only taken into account when columns (A) and (B) are 
known. 
Source Administrative data PD S2 Questionnaire 2014 
                                          
26 Reporting MSs: BG, CZ, EE, IE, EL, LV, LT, LU, HU, MT, PT, RO, SK, FI, UK and LI. 
27 However, note that this percentage applies to the contested decisions to refuse planned treatments 
abroad and not only for cases concerning PDs S2. 
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4. Parallel schemes 
Most of the reporting MSs issued PDs S2 exclusively for care that is included in the 
services provided for by the legislation of the MS (IT, LV, LT, PL, RO, FI and LI) 
(Table 8). 94% of the PDs S2 issued by EE were related to a treatment which is 
included in the services provided for by its legislation. BE, CZ and FI issued PDs S2 
both for care included  and not included in the services provided for by their national 
legislation. Only in EL and PT PDs S2 were issued exclusively for care that is not 
included in the services provided for by the legislation of these MS.  
Several MSs reported the existence of parallel procedures (BE, CZ, EE, LU, HU, NL, PT, 
RO, FI and LI) (Table A1.1 – Annex 1). BE is involved, amongst others, in a large 
number of cooperation agreements in border areas (i.e. IZOM, ZOAST …) where, 
depending on the cooperation agreement, prior authorisation (using PD S2) often 
becomes a simple administrative authorisation that is granted automatically. The 
number of prior authorisations issued for existing parallel schemes (5,430 in 2013) 
exceeds to a large extent the number of PDs S2 issued (1,190 in 2013) (see also 
Table 1). CZ has installed an authorisation procedure for cases where the PD S2 
cannot be issued.28 Also LU and LI authorise treatment outside the PD S2 scheme. EE 
states that the authorisation is based on their national legislation and that none of the 
PDs S2 were issued on the basis of Article 20 of Regulation (EC) No 883/2004 but 
rather on a ‘letter of guarantee’. Only in cases where the MS of stay specifically 
requested the PD S2, this form was issued.29 Also HU will issue a letter of guarantee 
for payment to the MS of treatment, but only when the PD S2 is not accepted. In PT a 
prior authorisation is installed by the Director-General of Health. RO will also 
reimburse the treatment provided without a prior authorisation. 
 
                                          
28 E.g. for care that is not included in the services provided for by the legislation of the competent MS. 
However, based on Table 8 we observe that 40% of the PDs S2 are issued for care that is not included in 
the services provided for by the Czech legislation. 
29 For only 52 (22%) of the 232 decisions of planned treatment a PD S2 was issued by EE.  
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Table 8 Care (not) included in the services provided for by the national legislation, 2013* 
MS For care that is included in the services 
provided for by the legislation of your MS 
For care that is not included in the 
services provided for by the legislation of 
your MS 
BE** n.a. n.a. 
BG n.a. n.a. 
CZ app. 60% app. 40% 
DK   
DE   
EE 94.2% 5.8% 
IE n.a. n.a. 
EL 0.0% 100.0% 
ES   
FR   
HR   
IT 100.0% 0.0% 
CY   
LV 100.0% 0.0% 
LT 100.0% 0.0% 
LU n.a. n.a. 
HU*** n.a. n.a. 
MT**** n.a. n.a. 
NL n.a. n.a. 
AT   
PL 100.0% 0.0% 
PT 0.0% 100.0% 
RO 100.0% 0.0% 
SI   
SK 100.0% 0.0% 
FI 55.9% 44.1% 
SE   
UK***** n.a. n.a. 
EU28   
IS   
LI 100.0% 0.0% 
NO   
CH   
Total   
* n.a.: no data available; blank: non-response. 
** BE: 171 PDs S2 issued for treatment which is not possible in BE due to medico-technical 
reasons. Some of these authorisations may be applicable to care that is not included in the 
services provided for by the national legislation. At least 1,019 (1,190 – 171) authorisations 
provided for care that is included in the services provided for by the national legislation. 
*** HU: the data given by HU on the PDs S2 issued are based on authorisations which were 
granted mostly for treatments not available in HU and only in a limited number for treatments 
included in the Hungarian list of services. In this sense, these cases do not strictly fall within 
the ambition of Regulation (EC) No 883/2004. There is no division in statistics on PD S2 
according to the issuance for services included or not included in the healthcare basket. 
**** MT: only the number of PDs S2 issued are reported without making a distinction 
between both possibilities. 
***** UK: due to changes in the systems of authorising and issuing PDs S2, it is not possible 
to provide an accurate position for 2013. 
Source Administrative data PD S2 Questionnaire 2014 
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5. Conclusion  
This report on the collection of data on PD S2 applies to reference year 2013 and was 
provided by the MSs on a voluntary basis. Given that the reporting exercise did not 
cover all MSs, the conclusions are to be assessed in the light of this limited data 
availability.      
Planned cross-border healthcare seems to be rather limited observing that for about 
15 out of 100,000 insured persons a PD U2 was issued in 2013. However, planned 
cross-border healthcare is broader than only the PD S2 scheme. Several MSs report 
the existence of parallel procedures.  
While the obligation of issuing prior authorisation in accordance with Article 20 of 
Regulation (EC) No 883/2004 refers to treatments that are among the benefits 
provided by the Member States providing the authorisation, a number of MS will issue 
a PD S2 even for also care that is not included in the services provided for by their 
legislation. 
There is no clear view on the main grounds to receive planned cross-border 
healthcare. Push and pull factors may have an impact. Geographical proximity is only 
one possible reason, and only applicable to a number of MSs. About 80% of the 
reported PDs S2 were issued by a neighbouring MS.     
Only 4.7% of the requests for a PD S2 were refused. There does not seem to be any 
indication of a different refusal rate depending on which MS is indicated as the 
destination where the scheduled treatment will be received. The most frequent reason 
to refuse a request for a PD S2 by the competent MS is reported to be the fact that 
care may be delivered within a medically acceptable period in the competent MS. 
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Annex 1 The existence of parallel schemes 
 Table A1.1 The existence of parallel schemes, 2013* 
MS YES/NO Description 
BE YES 1) principal residence in a border region; 
2) functional rehabilitation in DE for insured persons living in the German-speaking community; 
3) cooperation agreements which makes it easier to obtain prior authorisation in border areas 
(IZOM, ZOAST ...); 
4) PD S2 ‘maternity’ (Decided in the 254th meeting of the AC) for the benefit of pregnant 
women who, for personal reasons, wish to give birth in another MS. 
BG NO Not appliclable 
CZ YES In cases where the application relates to healthcare not included in the services provided for by 
the legislation of CZ, which is not covered according to the legislation of the other MS 
concerned that is subject to the application, or when the application relates to healthcare 
covered according to the legislation of the other MS concerned, but it has to be provided in a 
non-contractual healthcare facility, and is, however, the only option in terms of health condition 
of the patient in question, the Czech health insurance fund may consider granting approval to 
the applicant in accordance with § 16 of Act No. 48/1997 Coll., on public health insurance, as 
amended. In case such approval is granted, there is a direct payment made by the Czech health 
insurance fund to the healthcare facility providing the treatment. 
DK   
DE   
EE YES EE grants authorisation on the basis of their national legislation. The criteria for granting the 
authorisation are the following: 
1) healthcare service (or alternative) is not provided in EE; 
2) the provision of the healthcare service applied for by the insured person is therapeutically 
justified; 
3) the medical efficacy of the healthcare service applied for has been proved; 
4) the average probability of the aim of the health service applied for being achieved is at least 
50 per cent.  
If a board of doctors finds that these criteria are fulfilled EE grants the authorisation and issues 
a letter of guarantee to the healthcare facility or concludes a contract with the insured person 
on partial advance payment. EE only issues a PD S2 if the foreign healthcare facility does not 
accept the letter of guarantee and specifically requests the form. None of PDs S2 were issued 
on the basis of Article 20 of Regulation (EC) No 883/2004.  
Altogether, in 2013, EE made 232 decisions to send a person for a specific treatment abroad 
(EU, EFTA, CH). In most cases EE issued the letter of guarantee.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
IE n.a. n.a. 
GR n.a. n.a. 
ES   
FR   
HR   
IT NO There are no parallel procedures allowing patients to seek healthcare abroad. If it is not possible 
to use PD S2 because the healthcare abroad is provided in a private structure, patients who got 
the authorization can get the reimbursement. 
CY   
LV NO No parallel schemes. 
LT NO No parallel schemes. 
LU YES There are a few rare cases of authorisation outside the PD S2 scheme. This procedure is based 
on Article 20(2) of the Luxembourg Social Security Code and Article 26(3) and (4) of the CNS 
Regulations. The Social Security Medical Examiner authorises treatment outside the PD S2 
scheme, which is reimbursed on the basis of rates set by analogy with those applied in 
Luxembourg. 
HU** YES The number of S2 forms is not representative of numbers for planned treatment abroad. There 
are treatments in the EU where the health-care provider is a private provider; therefore they do 
not accept a PD S2 or no PD S2 is used for genetic testing.  
If the healthcare service care cannot be delivered in HU and there is a real chance for improving 
the quality of life of the patient, the competent institution gives authorisation for planned cross-
border treatment. For genetic and biochemical analysis’ or bone marrow donor search the 
competent institution does not issue a PD S2 because these centres request direct payment. In 
these cases the competent institution issues a guarantee letter for payment. 
MT n.a. n.a. 
NL YES A parallel scheme is in place under the health insurance act, since the health insurance act 
contains the principle of world coverage. Persons may apply for reimbursement of costs under 
the health insurance act, as long as the treatment is within the basket of care. 
AT   
PL n.a. n.a. 
PT YES 1. The Portuguese National Health System has legislation in force that recognises the right of 
patients to have access to specialised healthcare abroad which, for lack of technical or human 
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MS YES/NO Description 
means, cannot be provided within the Portuguese Health System.  
2. The process of medical assistance abroad is organised by the public hospital of the National 
Health Service where the patient is being treated and is subject to prior authorisation of the 
Director-General of Health.  
3. The hospital must specify the following:  
*The reasons  that underlie the impossibility, material and human, of the medical assistance to 
be provided in a national health institution; 
*The clinical aim of displacement; 
*Foreign healthcare Institutions (inside or outside the EU or EEA) where the patient can receive 
medical care and its fundaments; 
*The maximum period for the medical assistance; otherwise, it will not produce its normal, 
useful effect; 
*If the patient needs to be accompanied by a person, with or without adequate technical 
training; 
*A report with resource to consultants and experts of recognised competence in the clinical 
issues under appreciation. 
4. If the Director-General of Health authorises the patient to travel abroad, the National Health 
Service will assume the full payment of all medical expenses, accommodation, travel, meals and 
medication.  
5. The requests for medical assistance must be concluded within 15 days and, in cases of 
exceptional urgency, within five days. 
6. In 2013, 496 patients were authorised for treatment abroad under this legislation. 
7. The Director-General of Health has not authorised only two cases, insofar as the treatment 
was available in PT within a reasonable time. 
RO  Reimbursement of medical services provided to insured Romanians without prior authorisation 
in the MSs of the EU/EEA/CH.  
A parallel procedure is used when the insured person leaves the planned treatment without 
prior approval of the competent institution. The health insurance institution where the person is 
registered as an insured person will pay the value of medical services provided. According to 
Article 8 of CNAS Order No 729 of 17 July 2009 approving the Methodological Norms regarding 
reimbursement and recovery of the cost of healthcare provided under the provisions of 
international documents in the field of health to which RO is a party, as amended and 
supplemented, the reimbursement is made at the written request of the insured, a family 
member (parent, husband/wife, son/daughter) or persons authorised by him/her, accompanied 
by supporting documents. The health insurance fund reimburses the value of medical services 
provided and paid for, at the tariffs in RO provided for by regulations in force at the date of 
payment, for the insured person. 
SI   
SK n.a. n.a. 
FI  On the basis of the Finnish Health Care Act (1326/2010, 56§) also the hospital districts (forming 
a part of the public healthcare system) issued the form E112 until 31.12.2013. From 1.1.2014 
when the new Finnish Act on Cross border Health Care entered into force, 56§ of the Health 
Care Act was repealed and, accordingly, the hospital districts do not issue the E112 form 
anymore.                                                                                                                 
If a patient wants to receive healthcare abroad, the public healthcare unit in FI can also, if 
necessary, purchase this healthcare from abroad. In these cases the public healthcare unit in FI 
also pays directly to the healthcare provider abroad and the patient receives the healthcare as 
in FI (same client fee etc). 
SE   
UK*** n.a. n.a. 
IS   
LI YES In line with the national legislation (KVG FL), in certain cases it is possible and stipulated by 
agreement that services can or must be provided abroad (e.g. where not offered in LI or in the 
case of agreements with foreign service providers). 
NO   
CH   
* n.a.: no data available; blank: non-response. 
** HU: in 2013, 646 Hungarian patients received planned treatment abroad. This number 
contains 71 cases in which the patients did not leave the MS but bone marrow was delivered 
in HU. This total number differs from the 334 issued PDs S2 reported for HU in Table 1. 
*** UK: due to changes in the systems of authorising and issuing PDs S2, it is not possible to 
provide an accurate position for 2013. 
Source Qualitative data PD S2 Questionnaire 2014 
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Annex 2 Additional analysis of PDs S2 issued and 
received and refused requests 
 
Table A2.1 The percentage of insured persons who received a PD S2, 2013* 
MS Number of insured persons 
(A)** 
Number of PDs S2 issued 
(B) 
% of insured persons who 
received a PD S2 (B/A) 
BE 5,117,974 1,190 0.0023% 
BG 6,099,760 235 0.0039% 
CZ 10,415,087 100 0.0010% 
DK n.a.   
DE 69,800,000   
EE 1,231,203 52 0.0042% 
IE n.a. 683  
EL 9,950,000 486 0.0049% 
ES 3,991,706   
FR 58,800,000   
HR 4,349,133   
IT 58,901,313 4,933 0.0084% 
CY 438,796   
LV 2,262,302 174 0.0077% 
LT 2,986,863 74 0.0025% 
LU 762,410 17,538 2.3003% 
HU 9,463,727 334 0.0035% 
MT 205,549 33 0.0161% 
NL 16,774,183 1,264 0.0075% 
AT 8,567,710   
PL 35,261,020 88 0.0002% 
PT n.a. 28  
RO 18,107,722 1,049 0.0058% 
SI 2,079,143   
SK 5,197,880 769 0.0148% 
FI 5,447,051 59 0.0011% 
SE n.a.   
UK n.a. 1,216  
IS 325,671   
LI 37,910 261 0.6885% 
NO n.a.   
CH 8,060,000   
Total   0.0152% 
* n.a.: no data available; blank: non-response. 
** It is not always clear how MSs have interpreted the wording ‘insured person’. Some MSs 
might have used a narrow definition (excluding members of the family, pensioners …) (i.e. 
BE). 
Source Administrative data PD S2 Questionnaire 2014 and EHIC Questionnaire 2014 
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Table A2.2 PDs S2 issued, breakdown by receiving MS, 2013 (column %)*,**,*** 
Receiving 
MS 
BE BG CZ DK DE EE IE EL ES FR HR IT CY LV LT LU HU MT NL AT PL PT RO SI SK FI SE UK EU 
28 
IS LI NO CH 
BE 0.0 26.0 2.0   0.0 2.0 4.9    5.2  0.6 4.1 24.5 0.3 0.0 80.2  14.8 3.6 2.2  0.1 0.0  3.7   0.0   
BG 0.2 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.1  0.0 0.0  0.8   0.0   
CZ 0.2 0.0 0.0   0.0 0.0 0.0    0.1  0.0 0.0 0.0 0.0 0.0 0.2  0.0 0.0 0.1  76.3 0.0  3.6   0.0   
DK 0.1 0.0 0.0   0.0 0.0 0.0    0.0  2.3 2.7 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  0.2   0.0   
DE 44.5 50.6 30.0   38.5 0.9 23.0    17.0  33.3 37.8 57.9 28.4 0.0 16.1  50.0 10.7 43.6  6.8 38.2  6.7   0.4   
EE 0.1 0.0 0.0   0.0 0.0 0.0    0.0  13.8 13.5 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 32.4  0.1   0.0   
IE 0.0 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  1.1   0.0   
EL 0.1 0.4 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  0.6   0.0   
ES 0.9 0.4 0.0   1.9 0.0 0.0    0.8  0.0 0.0 0.1 0.0 0.0 0.0  0.0 14.3 0.4  0.0 2.9  16.4   0.0   
FR 26.1 8.1 0.0   0.0 0.0 16.3    26.3  0.6 1.4 14.2 1.8 0.0 0.8  2.3 57.1 11.5  0.7 5.9  11.0   0.0   
HR 0.0 0.0 6.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  0.1   0.0   
IT 0.5 2.6 0.0   0.0 0.1 16.9    6.2  0.0 0.0 0.3 0.0 42.4 0.0  4.5 7.1 12.1  0.1 2.9  2.5   0.0   
CY 0.1 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  0.2   0.0   
LV 0.0 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  0.1   0.0   
LT 0.0 0.0 0.0   0.0 0.0 0.0    0.0  37.9 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  1.2   0.0   
LU 4.4 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  0.2   0.0   
HU 0.0 0.0 1.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 3.6 5.6  0.0 0.0  2.3   0.0   
MT 0.0 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.1 0.0  0.0   0.0   
NL 19.0 0.4 5.0   1.9 0.9 0.2    0.5  3.4 20.3 0.3 0.0 0.0 0.0  3.4 0.0 0.5  0.5 0.0  1.6   0.0   
AT 0.2 7.2 1.0   0.0 0.1 18.9    3.6  0.0 0.0 0.1 28.7 0.0 0.0  2.3 0.0 22.5  13.3 0.0  1.0   1.9   
PL 0.1 0.9 1.0   0.0 1.2 0.0    0.4  0.6 8.1 0.0 0.0 0.0 0.0  0.0 0.0 0.1  0.4 0.0  34.8   0.0   
PT 0.1 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.2 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  0.2   0.0   
RO 0.0 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 2.9  0.2   0.0   
SI 0.0 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  0.0   0.0   
SK 0.0 0.0 8.0   0.0 0.0 0.0    0.1  0.6 0.0 0.0 0.3 0.0 0.0  0.0 0.0 0.1  0.0 0.0  7.9   0.0   
FI 0.1 0.0 3.0   30.8 0.0 0.0    0.0  2.3 0.0 0.0 0.0 0.0 0.1  0.0 0.0 0.0  0.0 0.0  0.4   0.0   
SE 0.0 2.6 1.0   5.8 4.1 1.4    0.4  1.1 0.0 0.1 0.3 0.0 0.0  2.3 0.0 0.0  0.1 5.9  1.0   0.0   
UK 2.0 0.4 2.0   21.2 90.3 13.6    2.6  2.3 4.1 0.1 1.5 0.0 0.2  14.8 3.6 0.5  0.5 2.9  0.8   0.0   
EU28 98.6 99.6 60.0   100 99.7 95.3    63.3  98.9 91.9 97.9 61.4 42.4 97.5  94.3 100 99.2  99.0 94.1  98.8   2.3   
IS 0.0 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  0.0   0.0   
LI 0.0 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  0.0   0.0   
NO 0.0 0.0 0.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.0  0.0 0.0  0.1   0.0   
CH 1.4 0.4 4.0   0.0 0.3 4.7    36.7  1.1 8.1 2.1 38.6 57.6 2.5  5.7 0.0 0.0  1.0 0.0  1.2   97.7   
N.s. 0.0 0.0 36.0   0.0 0.0 0.0    0.0  0.0 0.0 0.0 0.0 0.0 0.0  0.0 0.0 0.8  0.0 5.9  0.0   0.0   
Total 100 100 100   100 100 100.    100  100 100 100 100 100 100  100 100 100  100 100  100   100   
* blank: non-response. 
** □ = in top 3 as receiving MS. 
*** Red colour: neighbouring MS. 
Source Administrative data PD S2 Questionnaire 2014 
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Table A2.3 PDs S2 received, breakdown by issuing MS, 2013 (column %)*,**,*** 
Issuing 
MS 
BE BG CZ DK DE EE IE EL ES FR HR IT CY LV LT LU HU MT NL AT PL PT RO SI SK FI SE UK EU 
28 
IS LI NO CH 
BE 0.0 40.0 0.2    0.0        0.0 59.8 0.0    0.5  0.0  0.3 3.4  0.6      
BG 0.8 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.3 0.0  0.2      
CZ 0.0 0.0 0.0    0.0        0.0 0.0 0.0    0.2  0.0  62.3 0.0  0.0      
DK 0.1 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.3 0.0  1.1      
DE 1.3 20.0 4.1    0.0        0.0 9.2 66.7    27.7  50.0  7.2 0.0  0.5      
EE 0.0 0.0 0.0    0.0        0.0 0.0 2.1    0.0  0.0  0.0 55.2  0.5      
IE 0.1 0.0 0.0    0.0        0.0 0.0 0.0    2.0  0.0  0.0 0.0  80.4      
EL 0.6 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.0 0.0  5.6      
ES 0.2 0.0 0.9    0.0        0.0 0.5 0.0    0.7  0.0  0.3 31.0  0.6      
FR 8.1 0.0 0.9    0.0        0.0 28.9 2.1    1.0  0.0  0.3 0.0  0.5      
HR 0.0 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.0 0.0  0.0      
IT 4.5 0.0 1.1    0.0        0.0 0.2 2.1    2.0  0.0  0.7 0.0  5.0      
CY 0.0 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.0 0.0  1.1      
LV 0.1 0.0 0.0    0.0        98.0 0.0 0.0    0.0  0.0  0.0 3.4  0.2      
LT 0.0 0.0 0.0    0.0        0.0 0.0 0.0    1.7  0.0  0.0 0.0  0.4      
LU 33.5 0.0 0.0    0.0        0.0 0.0 4.2    0.0  0.0  0.0 0.0  0.7      
HU 0.1 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.3 0.0  0.1      
MT 0.0 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.0 0.0  0.0      
NL 48.7 0.0 0.1    0.0        0.0 1.0 0.0    1.2  0.0  0.0 0.0  0.5      
AT 0.1 0.0 0.6    0.0        0.0 0.0 2.1    0.2  0.0  4.5 0.0  0.3      
PL 0.4 0.0 0.2    0.0        0.0 0.0 6.3    0.0  0.0  0.3 0.0  0.5      
PT 0.1 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.0 0.0  0.0      
RO 0.5 0.0 0.2    0.0        0.0 0.0 10.4    0.0  0.0  0.3 0.0  0.4      
SI 0.1 0.0 0.2    0.0        0.0 0.0 0.0    0.0  0.0  0.0 0.0  0.4      
SK 0.2 0.0 80.7    0.0        0.0 0.0 0.0    0.0  0.0  0.0 0.0  0.1      
FI 0.1 0.0 0.0    0.0        0.0 0.1 0.0    0.0  0.0  0.0 0.0  0.0      
SE 0.1 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.0 6.9  0.3      
UK 0.6 40.0 10.6    100        2.0 0.4 4.2    62.0  50.0  21.9 0.0  0.0      
EU28 100 100 99.8   n.a. 100 n.a.    n.a.  n.a. 100 100 100 n.a. n.a.  99.3  100  99.3 100  99.7   n.a.   
IS 0.0 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.0 0.0  0.0      
LI 0.0 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.0 0.0  0.0      
NO 0.0 0.0 0.2    0.0        0.0 0.0 0.0    0.7  0.0  0.0 0.0  0.0      
CH 0.0 0.0 0.0    0.0        0.0 0.0 0.0    0.0  0.0  0.7 0.0  0.3      
Tot. 100 100 100   n.a. 100 n.a.    n.a.  n.a. 100 100 100 n.a. n.a.  100  100  100 100  100   n.a.   
* n.a.: no data available; blank: non-response. 
** □ = in top 3 as issuing MS. 
*** Red colour: neighbouring MS. 
Source Administrative data PD S2 Questionnaire 2014 
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Table A2.4 The percentage of refused requests,* 2013 (in %) 
Receiving 
MS BE BG CZ DK DE EE IE EL ES FR HR IT CY LV LT LU HU MT NL AT PL PT RO SI SK FI SE UK IS LI NO CH 
BE  7.6 50.0    6.7 0.0    1.5  50.0 0.0 2.3     7.1 0.0 4.2  50.0 100.0  0.0     
BG 33.3                      0.0  100.0 100.0  0.0     
CZ 66.7           12.5    28.6       0.0  6.4   0.0     
DK            100.0  20.0 0.0 80.0         100.0   0.0     
DE 13.7 7.0 31.8   4.8 25.0 13.8    3.0  4.9 0.0 3.4     26.7 62.5 2.8  3.7 31.6  0.0  0.0   
EE 0.0  100.0           7.7 0.0           69.4  0.0     
IE                0.0            0.0     
EL 66.7 50.0              0.0            0.0     
ES 26.7 0.0    0.0      16.7    30.0      33.3 33.3   50.0  1.0     
FR 26.3 5.0 100.0     2.5    2.0  0.0 0.0 3.0     50.0 15.8 2.4  37.5 0.0  1.5     
HR   0.0                         0.0     
IT 53.8 0.0 100.0    0.0 1.2    0.3    17.5     33.3 0.0 3.1  0.0 0.0  3.1     
CY 0.0                           0.0     
LV                          100.0  0.0     
LT              1.5              0.0     
LU 22.4           0.0                0.0     
HU 100  0.0         0.0    0.0      0.0 3.3  100.0   0.0     
MT                         0.0        
NL 32.9 50.0 0.0   0.0 0.0 0.0    4.0  25.0 0.0 9.6     0.0 100.0 16.7  0.0   0.0     
AT 33.3 10.5 66.7    50.0 1.1    6.3    20.0     0.0  2.5  6.4   0.0  0.0   
PL 80.0 0.0 0.0    11.1     0.0  0.0 0.0 40.0       0.0  0.0   0.0     
PT 50.0               27.5            0.0     
RO                100.0          0.0  0.0     
SI            0.0    0.0                 
SK   33.3         25.0  0.0         0.0     1.0     
FI 50.0  0.0   23.8      0.0  0.0  0.0            0.0     
SE  0.0 0.0   0.0 6.7 0.0    8.3  33.3  30.8     0.0    0.0 33.3  0.0     
UK 27.3 0.0 0.0   0.0 3.0 15.4    1.5  0.0 0.0 18.5     18.8 0.0 16.7  0.0 0.0  0.0     
EU28 23.3 7.5 29.4   10.3 3.7 6.8    2.7  6.0 0.0 3.4     22.4 28.2 3.1  7.0 53.6  0.5  0.0   
IS                                 
LI                                 
NO                            0.0     
CH 34.6 0.0 0.0    0.0 0.0    1.1  0.0 0.0 3.9     0.0  100.0  11.1 100.0  0.0  0.0   
Total 23.5 7.5 20.0   10.3 3.7 6.5    2.1  5.9 0.0 3.4     21.4 28.2 3.1  7.0 52.8  0.5  0.0   
* Refused requests= PDs S2 refused / (PDs S2 issued + PDs S2 refused) 
Source Administrative data PD S2 Questionnaire 2014
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Annex 3 Country abbreviations 
Table A3 Country abbreviations 
Abbreviation Country 
BE Belgium 
BG Bulgaria 
CZ Czech Republic 
DK Denmark 
DE Germany 
EE Estonia 
IE Ireland 
EL Greece 
ES Spain 
FR France 
HR Croatia 
IT Italy 
CY Cyprus 
LV Latvia 
LT Lithuania 
LU Luxembourg 
HU Hungary 
MT Malta 
NL Netherlands 
AT Austria 
PL Poland 
PT Portugal 
RO Romania 
SI Slovenia 
SK Slovak Republic 
FI Finland 
SE Sweden 
UK United Kingdom 
IS Iceland 
NO Norway 
LI Liechtenstein 
CH Switzerland 
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Annex 4 PD S2 Questionnaire 
1/ Countries in which patients have been authorised to receive care by the 
reporting Member State (= number of issued S2 forms) 
Each Member State shall indicate "not applicable" in its own row. 
N.B. This is determined by the dates of the decisions to issue authorisation for issuing 
an S2 form, even if the request for authorisation was received in year N-1. 
 
Member State  Number of S2 forms issued in year N for each State  
BE  
CZ  
DK  
DE  
EE  
EL  
ES  
FR  
IE  
IT  
CY  
LV  
LT  
LU  
HU  
MT  
NL  
AT  
PL  
PT  
SK  
SI  
FI  
SE  
UK  
BG  
RO  
IS  
LI  
NO  
CH  
Total number of S2 
forms issued by the 
reporting country for 
care in other Member 
State 
 
 
2/ Countries from which patients have been authorised to receive care in the 
reporting Member State (= number of received S2 forms) 
Each Member State shall indicate "not applicable" in its own row. 
N.B. This is determined by the dates the S2 form was received by the appropriate 
healthcare institution in the reporting country under in year N. 
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Member State  Number of S2 forms received in year N from each State 
BE  
CZ  
DK  
DE  
EE  
EL  
ES  
FR  
IE  
IT  
CY  
LV  
LT  
LU  
HU  
MT  
NL  
AT  
PL  
PT  
SK  
SI  
FI  
SE  
UK  
BG  
RO  
IS  
LI  
NO  
CH  
Total number of S2 
forms received by the 
reporting Member 
State 
 
 
3/ Countries in which patients have been refused by the reporting Member 
State authorisations to receive care (= number of refused S2 forms) 
Each Member State shall indicate "not applicable" in its own row. 
N.B. This is determined by the dates of the decisions to refuse authorisation for 
issuing an S2 form, even if the request for authorisation was received in year N-1. 
 
Member State  Number of S2 forms refused in year N for each State  
BE  
CZ  
DK  
DE  
EE  
EL  
ES  
FR  
IE  
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IT  
CY  
LV  
LT  
LU  
HU  
MT  
NL  
AT  
PL  
PT  
SK  
SI  
FI  
SE  
UK  
BG  
RO  
IS  
LI  
NO  
CH  
Total number of S2 
forms refused by the 
reporting country for 
care in other Member 
State 
 
 
4/ Reasons for refusals to issue an S2 form  
 
(Reason 1): the care in question is not included in the services provided for by the 
legislation of your Member State  
(Reason 2): the care in question may be delivered within a medically acceptable 
period in the competent State   
(Reason 3): other circumstances (for example: incomplete file, non-compliance with 
procedures, institution requesting a second opinion).  
 
N.B. This is determined by the dates of decisions to refuse authorisation for issuing an 
S2 form, even if the request for authorisation was received in year N-1. 
 
Year Number of refusals 
for Reason 1 
Number of refusals for 
Reason 2 
Number of refusals for 
Reason 3 
N    
 
 
5/ Number of contested decisions to refuse authorisation to issue an S2 form 
in year N 
 
Year Number of contested decisions to refuse to issue an S2 form 
N  
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6/ Number of S2 forms issued 
-For care that is included in the services provided for by the legislation of your 
Member State  
-For care that is not included in the services provided for by the legislation of your 
Member State  
 
 
 
 
7/ It is possible that the number of S2 forms is not representative of the 
number of patients covered for health care abroad for certain Member States, 
on account of the existence of parallel procedures allowing patients to seek 
healthcare abroad. 
 
Please describe, if applicable, the existence of parallel schemes to the S2 system, the 
procedures how these schemes work and their consequences for the people 
concerned. 
 
 
 
 
8/ Your explanatory comments on the data forwarded 
If necessary, please make any comments that may make it easier to understand the 
data transmitted in accordance with your national legislation or practice. 
 
 
 
 
